Influenza A Virus (A/District of Columbia/27/2023) HA (H3N2) Protein, His Tag (MALS verified)

Customer Reviews
Cat. No. / Size
Price
Qty
H32-V52H5-100ug
$360.00
H32-V52H5-1mg (500ug X 2)
$2760.00
ETA of in-stock products:2 business days

Product Details

  • Synonym

    Hemagglutinin/HA (Influenza Virus)

  • Source

    Influenza A Virus (A/District of Columbia/27/2023) HA (H3N2) Protein, His Tag (H32-V52H5) is expressed from human 293 cells (HEK293). It contains AA Gln 17 - Asp 529 (Accession # EPI2990337, GISAID).

    Predicted N-terminus: Gln 17

    Request for sequence

  • Molecular Characterization

    Hemagglutinin/HA (Influenza Virus) Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 62.7 kDa . The protein migrates as 80-95 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

    The protein is designed as a trimer.

  • Endotoxin

    Less than 1.0 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 0.1 M Sodium citrate, pH5.5 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    Hemagglutinin/HA (Influenza Virus) SDS-PAGE

    Influenza A Virus (A/District of Columbia/27/2023) HA (H3N2) Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    Hemagglutinin/HA (Influenza Virus) SEC-MALS

    The purity of Influenza A Virus (A/District of Columbia/27/2023) HA (H3N2) Protein, His Tag (Cat. No. H32-V52H5) is more than 95% and the molecular weight of this protein is around 240-275 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     Hemagglutinin/HA (Influenza Virus) ELISA

    Immobilized Influenza A Virus (A/District of Columbia/27/2023) HA (H3N2) Protein, His Tag (Cat. No. H32-V52H5) at 1 μg/mL (100 μL/well) can bind Human Anti-HA (H3N2) antibody CR8020 Human IgG1 with a linear range of 0.5-8 ng/mL (QC tested).

    Protocol
  • Bioactivity-SPR

     Hemagglutinin/HA (Influenza Virus) SPR

    Monoclonal Anti-HA (H3N2) Antibody, Human IgG1 (CR8020) captured on Protein A Chip can bind Influenza A Virus (A/District of Columbia/27/2023) HA (H3N2) Protein (Cat. No. H32-V52H5) with an affinity constant of 2.03 pM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol

Customer Reviews
Writing Reviews

Background

Influenza, commonly known as 'the flu', is an infectious disease of birds and mammals caused by RNA viruses of the family Orthomyxoviridae, the influenza viruses. The virus is divided into three main types (Influenzavirus A, Influenzavirus B, and Influenzavirus C), which are distinguished by differences in two major internal proteins (hemagglutinin (HA) and neuraminidase (NA), which are the most important targets for the immune system. Hemagglutinin binds to the sialic acid-containing receptors on the surface of host cells during initial infection and at the end of an infectious cycle which makes it a great target for vaccine studies.

Recent Advances

 
Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background